To determine whether the regulation of ASXL3 by BET inhibitors were cell type specific, we treated another two SCLC cell lines, NCI-H748 and NCI-H1882, with dBET6, JQ1, and IBET-151 for 8 h. This evidence concerns the gene DNER and small cell lung carcinoma.